Fig. 4

Plasma concentration-time profiles of cryptolepine after single intravenous (1 mg/kg) administrations to Sprague Dawley rats. The lower dotted line indicates the LLOQ (2.2 nM) of LC–MS/MS method for quantifying cryptolepine in rat plasma
Plasma concentration-time profiles of cryptolepine after single intravenous (1 mg/kg) administrations to Sprague Dawley rats. The lower dotted line indicates the LLOQ (2.2 nM) of LC–MS/MS method for quantifying cryptolepine in rat plasma